Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1976-6-2
pubmed:abstractText
Adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] activity of purified secretory vesicle membranes from the adrenal medulla is inhibited by I-isoproterenol and I-epinephrine, as well as by nerve growth factor (NGF). The effect of these agents was found to be dose-dependent and, in the case of the catecholamines, saturable. NGF was active at concentrations as low as 10(-8) M. Oxidized NGF was only minimally active, and insulin was completely inactive. Neither dopamine nor phenylephrine had activity. Inhibition of cyclase by either isoproterenol or epinephrine was blocked by I-propranolol, a specific beta-antagonist, but propranolol by itself had no effect on adenylate cyclase activity. The data indicate that the secretory vesicle membrane has beta-adrenergic receptors coupled to the adenylate cyclase. Propranolol was also found to block the NGF-induced inhibition of cyclase. We conclude that the granule membrane has beta-adrenergic receptors as well as NGF-reactive sites, and that the two may be functionally linked.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-13930092, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-14013351, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-167023, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-174074, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-234470, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4152316, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4270045, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4286175, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4316427, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4318781, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4324760, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4358441, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4369202, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4390109, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4827395, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4982360, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-4994719, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-50114, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-5032347, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-5072380, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-5283951, http://linkedlifedata.com/resource/pubmed/commentcorrection/3780-6032982
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
771-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1976
pubmed:articleTitle
Control of adenylate cyclase from secretory vesicle membranes by beta-adrenergic agents and nerve growth factor.
pubmed:publicationType
Journal Article